HIV-Negative Rifampicin Resistance/Multidrug-Resistant Extrapulmonary Tuberculosis in China from 2015 to 2019: A Clinical Retrospective Investigation Study from a National Tuberculosis Clinical Research Center

BACKGROUND: China is the region with a high global burden of rifampicin resistance/multidrug-resistant tuberculosis (RR/MDR-TB) and low HIV incidence. Our aim was to assess the clinical and demographic characteristics of RR/MDR-extrapulmonary tuberculosis (EPTB) from 2015 to 2019 to provide evidence...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Jun, Liu, Hongcheng, Wang, Jingjing, Li, Wenting, Fan, Lin, Sun, Wenwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943829/
https://www.ncbi.nlm.nih.gov/pubmed/35340674
http://dx.doi.org/10.2147/IDR.S342744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8943829/
https://www.ncbi.nlm.nih.gov/pubmed/35340674
http://dx.doi.org/10.2147/IDR.S342744

Ejemplares similares